BABA vs BROS

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong revenue and earnings growth, elevated valuation multiples—P/E of 124.43 and Price/Book of 11.80—suggest the stock is pricing in aggressive future expectations. Profitability margins and ROE are above sector averages, but insider selling worth over $600M in the last six months raises concern about confidence at the top. Analysts maintain a strong_buy consensus, yet technical trend and recent price performance show weakness, indicating potential near-term headwinds.